303 related articles for article (PubMed ID: 24321733)
1. Metabolomics in diabetes.
Zhang AH; Qiu S; Xu HY; Sun H; Wang XJ
Clin Chim Acta; 2014 Feb; 429():106-10. PubMed ID: 24321733
[TBL] [Abstract][Full Text] [Related]
2. Power of metabolomics in biomarker discovery and mining mechanisms of obesity.
Zhang A; Sun H; Wang X
Obes Rev; 2013 Apr; 14(4):344-9. PubMed ID: 23279162
[TBL] [Abstract][Full Text] [Related]
3. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
Wang X; Zhang A; Sun H
Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics in diabetes research.
Friedrich N
J Endocrinol; 2012 Oct; 215(1):29-42. PubMed ID: 22718433
[TBL] [Abstract][Full Text] [Related]
5. Mining of protein based biomarkers for type 2 diabetes mellitus.
Khan AR; Awan FR
Pak J Pharm Sci; 2012 Oct; 25(4):889-901. PubMed ID: 23010011
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
7. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes.
Connor SC; Hansen MK; Corner A; Smith RF; Ryan TE
Mol Biosyst; 2010 May; 6(5):909-21. PubMed ID: 20567778
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics of Type 1 and Type 2 Diabetes.
Arneth B; Arneth R; Shams M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109071
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
[TBL] [Abstract][Full Text] [Related]
10. NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis.
Zhang AH; Sun H; Qiu S; Wang XJ
Magn Reson Chem; 2013 Sep; 51(9):549-56. PubMed ID: 23828598
[TBL] [Abstract][Full Text] [Related]
11. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment.
Zhang A; Sun H; Wang X
Appl Biochem Biotechnol; 2012 Nov; 168(6):1718-27. PubMed ID: 22971835
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.
Abu Bakar MH; Sarmidi MR; Cheng KK; Ali Khan A; Suan CL; Zaman Huri H; Yaakob H
Mol Biosyst; 2015 Jul; 11(7):1742-74. PubMed ID: 25919044
[TBL] [Abstract][Full Text] [Related]
13. Modern analytical techniques in metabolomics analysis.
Zhang A; Sun H; Wang P; Han Y; Wang X
Analyst; 2012 Jan; 137(2):293-300. PubMed ID: 22102985
[TBL] [Abstract][Full Text] [Related]
14. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry.
Tsutsui H; Maeda T; Min JZ; Inagaki S; Higashi T; Kagawa Y; Toyo'oka T
Clin Chim Acta; 2011 May; 412(11-12):861-72. PubMed ID: 21185819
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics in diagnosis and biomarker discovery of colorectal cancer.
Zhang A; Sun H; Yan G; Wang P; Han Y; Wang X
Cancer Lett; 2014 Apr; 345(1):17-20. PubMed ID: 24333717
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
[TBL] [Abstract][Full Text] [Related]
17. NMR metabolomics identifies over 60 biomarkers associated with Type II Diabetes impairment in db/db mice.
Mora-Ortiz M; Nuñez Ramos P; Oregioni A; Claus SP
Metabolomics; 2019 Jun; 15(6):89. PubMed ID: 31179513
[TBL] [Abstract][Full Text] [Related]
18. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications.
Wang N; Zhu F; Chen L; Chen K
Life Sci; 2018 Nov; 212():194-202. PubMed ID: 30243649
[TBL] [Abstract][Full Text] [Related]
19. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics approaches and applications in prostate cancer research.
Zhang A; Yan G; Han Y; Wang X
Appl Biochem Biotechnol; 2014 Sep; 174(1):6-12. PubMed ID: 24838846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
